Innoviva, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $411.3M | $358.7M | $310.5M | $331.3M | $391.9M |
| Gross profit | $307.7M | $296.2M | $246.0M | — | — |
| Operating income | $163.7M | $166.9M | $113.9M | — | $375.1M |
| Operating expenses | $143.9M | $129.3M | $132.2M | — | $16.8M |
| Cash from operations | $196.9M | $188.7M | $141.1M | $201.7M | $363.8M |
| Capital expenditure | $1.1M | $270,000 | $411,000 | $67,000 | $0 |
| Free cash flow | $195.8M | $188.4M | $140.7M | $201.7M | $363.8M |
| Share repurchases | $4.5M | $14.8M | $75.7M | $8.5M | $394.1M |
| Impairments | $0 | $0 | $0 | — | — |
| Total assets | $1.6B | $1.3B | $1.2B | $1.2B | $926.4M |
| Total debt | $257.7M | $448.3M | $446.2M | $540.4M | $394.7M |
Shares outstanding 73.8M · Free float 11.3%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.